Reminder: Invitation to Roche’s Pharma Day 2024 Donnerstag, 19. September 2024 - 10:37

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 30 September 2024, starting at 09:00 BST and will finish at 14:30 BST with a reception.

The Roche Pharma Day will address the following topics:

• Group strategy / Pharma strategy / R&D Excellence
• Commercial growth drivers
• Pipeline updates
  • Oncology/Hematology, Neurology, Ophthalmology, Immunology, Cardiovascular and Metabolism

Presenters will include:

• Thomas Schinecker, CEO Roche Group
• Teresa Graham, CEO Roche Pharmaceuticals
• Levi Garraway, EVP, Head of Product Development and Chief Medical Officer
• Charles Fuchs, SVP, Global Head of Hematology and Oncology Product Development
• Azad Bonni, SVP, Global Head of Neurology & Rare Diseases pRED
• Larry Tsai, SVP, Global Head of Immunology Product Development
• Christopher Brittain, SVP, Global Head of Ophthalmology Product Development
• Manu Chakravarthy, SVP, Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development

You will have the opportunity to meet senior management during the event.

Meeting information: 

Date/Time (BST):

Monday, 30 September 2024
09:00 Registration
09:30 Event starts
14:30 Event ends, followed by refreshments with the Roche Management Team

Venue
etc.venues St Paul's
200 Aldersgate
London EC1A 4HD
map

To register for the event, please follow this > link (passcode: Pharma2024)

The slides will be available for download at 8:30 BST on the day of the event.
> click here

Alternatively you may participate virtually in the webinar (no access to speakers, pre-registration required). Please pre-register for the webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com .

A replay of the event will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com